Dehydrated Human Amnion/Chorion Membrane as Adjunctive Therapy in the Multidisciplinary Treatment of Pyoderma Gangrenosum: A Case Report.
暂无分享,去创建一个
[1] T. Koob,et al. Cytokines in single layer amnion allografts compared to multilayer amnion/chorion allografts for wound healing. , 2015, Journal of biomedical materials research. Part B, Applied biomaterials.
[2] R. Snyder,et al. The use of human amnion/chorion membrane in the clinical setting for lower extremity repair: a review. , 2015, Clinics in podiatric medicine and surgery.
[3] Marissa J Carter,et al. A multicenter, randomized, controlled clinical trial evaluating the use of dehydrated human amnion/chorion membrane allografts and multilayer compression therapy vs. multilayer compression therapy alone in the treatment of venous leg ulcers , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[4] T. Koob,et al. Angiogenic properties of dehydrated human amnion/chorion allografts: therapeutic potential for soft tissue repair and regeneration , 2014, Vascular cell.
[5] R. Kelly,et al. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent. , 2013, Journal of the American Academy of Dermatology.
[6] T. Serena,et al. A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers , 2013, International wound journal.
[7] R. Snyder,et al. Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. , 2012, Wounds : a compendium of clinical research and practice.
[8] R. Kirsner,et al. Dynamic reciprocity in the wound microenvironment , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[9] Robert J Snyder,et al. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. , 2010, Ostomy/wound management.
[10] E. Ruocco,et al. Pyoderma gangrenosum: an updated review , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[11] P. Blume,et al. Comparison of Negative Pressure Wound Therapy Using Vacuum-Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers , 2008, Diabetes Care.
[12] G. Dunnill,et al. Diagnosis and treatment of pyoderma gangrenosum , 2006, BMJ : British Medical Journal.
[13] A. Heiligenhaus,et al. Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea. , 2005, Investigative ophthalmology & visual science.
[14] Thomas John,et al. Human amniotic membrane transplantation: past, present, and future. , 2003, Ophthalmology clinics of North America.
[15] P. R. Dahl,et al. Skin ulcers misdiagnosed as pyoderma gangrenosum. , 2002, The New England journal of medicine.
[16] D. H. Ma,et al. Identification of Antiangiogenic and Antiinflammatory Proteins in Human Amniotic Membrane , 2000, Cornea.
[17] A. Fleischer,et al. Pyoderma Gangrenosum A Comparison of Typical and Atypical Forms with an Emphasis on Time to Remission. Case Review of 86 Patients from 2 Institutions , 2000, Medicine.
[18] R. Snyder,et al. Cadaveric allograft as adjunct therapy for nonhealing ulcers. , 1999, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.
[19] S. Burge,et al. Lesson of the week: Early diagnosis of pyoderma gangrenosum is important to prevent disfigurement , 1998, BMJ.
[20] J. Gruss,et al. Human amniotic membrane: a versatile wound dressing. , 1978, Canadian Medical Association journal.
[21] J. Pigeon. Treatment of second-degree burns with amniotic membranes. , 1960, Canadian Medical Association journal.